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Available online xxxxObjective: The advantages and disadvantages of using “epileptic” as a noun to describe someone with epilepsy
have long been debated. Recent high-proﬁle recommendations have stated that the term should not be used, in-
cluding in English, as it perpetuates stigma. This decision was largely informed by a Brazilian Global Campaign
Against Epilepsy study that reported experimental evidence indicating that, with students, the label evokes
more negative attitudes than “person with epilepsy”. The generalizability of this effect to different countries/
cultures, and thus the justiﬁcation for the recommendations, has never been tested.
Methods:We replicated the Brazilian study in the UK, in English, while also addressing methodological limita-
tions. Itwas powered to detect the effects reported by the Brazilian study, with 234 students completing a survey
regarding epilepsy attitudes. Half were randomized to Group 1 and half to Group 2. In Group 1, patients were
referred to as “people/personwith epilepsy”within the attitudinalmeasures,while inGroup2 theywere referred
to as “epileptic/s”. Measures included translations of the questions used in the Brazilian study and the Attitudes
and Beliefs about Living with Epilepsy scale. Participants' epilepsy familiarity and knowledgewere also assessed.
Results: The two groups were comparable in characteristics. A comparison of their responses to the attitude
measures revealed no statistically signiﬁcant or meaningful differences.
Conclusions: In this English replication, the word “epileptic” did not provoke more negative attitudes. This sug-
gests that the effect reported by the Brazilian study might be culturally dependent. Methodological limitations
to that study might also be relevant. Our results have implications for the global debate about how negative
attitudes towards epilepsy might be addressed. Simply not saying “epileptic” may not promote the positive
attitudes towards epilepsy that had been expected. To know how to best refer to those with epilepsy, evidence
on the preferences of those actually living with epilepsy is needed.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Culture1. Introduction
The history of epilepsy shows that the condition has attracted many
wayward theories about its cause and treatment [1]. Surveys from
around theworld show that thosewith epilepsy can still be viewed neg-
atively and subject to derogatory stereotypes [2–5]. Feeling stigmatized
because of one's epilepsy is associated with increased psychopathology
and reduced quality of life [6,7]. Therefore, it is important to identify
ways to address negative attitudes and attenuate stigma. One way
might be through language. It has been suggested that the language
and terms used when talking about epilepsy may shape attitudes
towards the condition and not just reﬂect them [8–14].logical Sciences, Institute of
iversity of Liverpool, Liverpool
5537.
. This is an open access article underThe word “epileptic”, when used as a noun to describe someone
with epilepsy, is one term that has, for a long time, attracted particular
attention [15]. Although still widely used [16], it can be divisive
[17,18]. To date, those with epilepsy have not been systematically
asked for their views. However, some commentators contend that the
term renders the individual human being as ‘invisible’ and equates
them completely with an attribute (i.e., epilepsy) that has negative con-
notations [8,12,19,20]. For this reason, some epilepsy advocacy groups
in different countries ask for the term not to be used and recommend
‘person-ﬁrst language’ instead (i.e., “person/people with epilepsy”)
[15,21–24]. ‘Person-ﬁrst language’ is considered less negative as it
afﬁrms personhood before disability, and so, may not negatively
constrain expectations of those being referred to.
On the other side of the debate, there are those who disagree with
attempts to dictate what language can and cannot be used. One reason
is that the process might be counterproductive in promoting contact
between those with and without epilepsy. For example, at a recentthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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some terms as acceptable and others as not could inhibit people from
talking about and asking about epilepsy through fear of causing offense.
It was also seen to risk alienating those who have or who do use
‘unacceptable’ terms. One further reason why some do not agree with
the move is that ‘person-ﬁrst language’ has been argued to preclude
the possibility of pride in one's identity by purposefully separating the
individual from his/her disability. Indeed, Vaughan [26] suggests
‘person-ﬁrst language’ violates a common principle thatmost adjectives
with positive connotations precede nouns.
Issues regarding how best to refer to someone with a health
condition are not unique to epilepsy [27,28]. However, something
which has recently set epilepsy apart is Fernandes et al.'s study [8],
conducted as part of the Global Campaign Against Epilepsy. In an article
titled Stop saying “epileptic”, they presented experimental evidence,
which appeared to demonstrate that, when compared to the appellation
“person with epilepsy”, “epileptic” provoked more negative attitudes
towards those with epilepsy.
Their study was conducted with Portuguese speakers in Brazil.
Participants were students without epilepsy who had been identiﬁed
as being academically “gifted” ([8], p. 1281). Two groups were formed
from those recruited, and participants were individually read four
questions by an experimenter. These asked the participants whether
they believed those with epilepsy would be rejected by society, have
difﬁcultieswith employment, and have difﬁculties in school andwheth-
er they themselves were prejudiced towards those with epilepsy. For
one group, “people with epilepsy” was used within the questions to
refer to those with epilepsy, while for the other, “epileptics” was used.
The subtle difference appeared to have a large effect, with those asked
about “epileptics” anticipating signiﬁcantly more social discrimination.
They said patients were more likely to be “rejected” by society (87%
vs. 41%) and that they would experience more employment (93% vs.
62%) and school (70% vs. 37%) difﬁculties.
On the basis of these results, Fernandes et al. [8] made the broad
recommendation that “epileptic” be abandoned and “person with
epilepsy” used. Their ﬁndings have since been well cited [12,29–31].
The study is, for example, the only scientiﬁc study cited by the US Insti-
tute of Medicine to support its recent recommendation that “epileptic”
not be usedwhen speaking in English [12]. It remains unclear, however,
whether such a move is justiﬁed as Fernandes et al.'s study was not
without limitations. Their allocation of participants to the two
conditions was not randomized nor was the knowledge of epilepsy
of those in the two groups or their familiarity with the condition
compared. Consequently, unknown differences between the partici-
pants in the two groups might account for their different responses.
The attitudinal questions used by Fernandes et al. also principally
related to a person's expectation of society's reaction to those with
epilepsy. The effect of the label on a person's own attitudes was not
sufﬁciently assessed.
Perhapsmost importantly, however, it remains unclear whether the
effect found in Brazil generalizes to different languages, cultures, and
contexts. It has been largely assumed that it does. That this assumption
has been made and that such limited evidence has formed the basis of
recommendations are disappointing. Discussions about such a serious
and emotive issue as epilepsy-related stigma need to be grounded
within robust scientiﬁc evidence. To not do so could mean that any
resulting recommendations are viewed with cynicism, not adhered to,
and so not bring about the beneﬁcial impact that they aim to.
The main aim of the present study was, therefore, to replicate
Fernandes et al.'s [8] study in a different language and culture to deter-
mine if the effect is as universal as has been assumed. Using English
translations of the questions used by Fernandes et al. [8], we completed
the study in the UK. English is the third most widely ﬁrst-spoken
language worldwide [32] and the international language of science. To
overcome the limitations of Fernandes et al.'s study, we randomized
our participants to groups and included additional measures to allowus to examine the effect of the label onparticipants' attitudes and to per-
mit us to compare the equivalence of our two groups' preexisting
knowledge and familiarity with epilepsy.
2. Methods
2.1. Participants
Participants were students studying psychology or medicine at the
University of Liverpool. All were aged ≥17 years, lived in the UK, and
were able to access the internet. People were excluded if they could
not provide informed consent or independently complete question-
naires in English.
2.2. Procedure
During November 2015, we completed a cross-sectional online
survey. Participants were recruited by an advertisement sent to those
within the schools of psychology and medicine. Persons wanting to
take part were directed to an online survey page hosted by Qualtrics.
Those agreeing to participate were randomly allocated by computer
software to one of two conditions. For Group 1, the term “person with
epilepsy” was used in the attitudinal measures when referring to an
individual and “people with epilepsy”when a group was referred to. For
Group 2, the terms “epileptic” and “epileptics”were used. Randomization
was 1:1 between the two conditions. Participation was anonymous.
The University of Liverpool's Institute of Psychology, Health and
Society Research Ethics Committee approved the study (IPHS-1516-33).
Informed consent was obtained from all participants.
2.3. Measures
2.3.1. Primary outcome measure
Within their article, Fernandes et al. [8] provided only English
translations of the four questions they used as their primary outcome
measure. We used these as our primary outcome measure, and these
were the ﬁrst questions our participants were asked to respond to.
Speciﬁcally, participants were asked to select either “Yes” or “No” to
each of the following questions.
1 “Do you think that peoplewith epilepsy/epileptics are rejected by the
society?”
2 “Do you think that people with epilepsy/epileptics have more difﬁ-
culties getting employed?”
3 “Do you think that peoplewith epilepsy/epileptics havemore difﬁcul-
ties at school?”
4 “Are you prejudiced towards people with epilepsy/epileptics?”
2.3.2. Secondary outcome measure
To be able to measure what effect the experimental manipulation
had for participants' attitudes (rather than on expectations of how
society would respond to those with epilepsy), participants, after
completing the primary outcome measure, completed the Attitudes
and Beliefs about Living with Epilepsy (ABLE) scale. The ABLE scale
was developed and validated by Dilorio et al. [33] and Kobau andDilorio
[34]. It assesses attitudes and beliefs using 30 items across 4 subscales:
(a) Negative Stereotypes (e.g., “I believe peoplewith epilepsy/epileptics
should not marry”), (b) Risk and Safety Concerns (e.g., “I believe people
with epilepsy/epileptics should not drive, even if the law allows them to
get a driver's license”), (c) Work and Role Expectations (e.g., “I believe
people with epilepsy/epileptics can do anything I can do”), and
(d) Personal Fear and Social Avoidance (e.g., “I believe being around a
person with epilepsy/an epileptic would make me uncomfortable”).
Participants rated their level of agreement to each item on a 6-point
Likert scale. Possible response options range from “Strongly agree” to
“Strongly disagree”. Subscale scores are calculated using the mean
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therefore, 1 to 6. After recoding items scored in reverse, higher scores
for all subscales indicate more negative attitudes towards epilepsy.
The terms used to refer to those with epilepsy within the ABLE
measure were adapted so that they accorded with the condition the
participant was randomized to.2.3.3. Covariate measures
Participants were asked for their age, sex, ethnicity, and education.
To obtain information about their knowledge and familiarity with
epilepsy, the following instruments were used:
Epilepsy Knowledge: Participants completed 25 items from the
Epilepsy Knowledge Proﬁle — General [35]. It requires participants to
respond either “True” or “False” to statements that reﬂect factual
information and common misconceptions about epilepsy. Seventeen
items related tomedical aspects (e.g., “Epilepsy is a symptom of mental
illness”) and 8 to social aspects (e.g., “Most children with epilepsy can
attend normal schools”). This widely used measure has been found to
be valid and reliable [35]. Higher scores indicate greater knowledge.
Familiarity with Epilepsy Questionnaire: This was drawn from
established questions from Caveness and Gallup's [36] survey of public
attitudes towards epilepsy. As well as being asked whether they
themselves have epilepsy, participants were asked whether they had
ever seen anyone having a seizure and whether they knew anyone
who had epilepsy, and if so, who?
The latter two measures were completed at the end of the survey,
and no adjustment to their original wording was made.2.4. Statistics
2.4.1. Sample size
The principal aim of this study was to determine if the effect detected
by Fernandes et al. could be found when the experiment was completed
in English. To ensure adequately powered investigations, we based the
study's sample size on the smallest of the statistically signiﬁcant
differences Fernandes et al. found on their primary outcome measure
(namely, Question 2). A sample of N = 106 participants (53 per group)
with complete data was calculated as being required to provide 95%
power to detect the effect using independent samples t-tests with
2-sided 1% signiﬁcance tests.2.4.2. Analyses
Descriptive statisticswere used to examine the participants' age, sex,
education, ethnicity, and familiarity and knowledge of epilepsy and to
compare the two randomized groups. Differences in mean and propor-
tions, along with 95% conﬁdence intervals (CIs), are reported.
To test for differences in the two groups' responses to Fernandes
et al.'s questions, chi-square tests were used, while independent
t-tests were used to compare the two groups' scores on each of the
ABLE subscales.
To explore if any of the participants' characteristics were associated
with their responses to the outcome measures, unadjusted regression
models were run to determine the relationship between each of the
characteristics and responses. For Fernandes et al.'s questions, logistic
regression, with robust standard errors, was used. For the ABLE scale,
scores were treated as continuous, and linear regression, with robust
standard errors, was used. Any variables signiﬁcantly associated
(P b 0.05) with a dependent variable of interest were simultaneously
entered into multiple regression analyses to identify parsimonious
predictors. Odds ratios (ORs) alongwith 95%CIs are presented for logistic
regression, while unstandardized coefﬁcients (B) and R2 are presented
for linear regression. Analyses were completed using Stata 11 (Stata
Corporation, College Station, TX, USA) and StatsDirect 2.7.8 (StatsDirect
Ltd., Cheshire, United Kingdom).3. Results
3.1. Participants
A total of 266 participants were recruited. Of these, 234 (87.9%) had
complete data for the primary, secondary, and covariate measures.
There were no statistically signiﬁcant differences between those
with and without missing data in age, sex, or ethnicity (all P N 0.05).
Therefore, subsequent analyses were performed with those with
complete data.
The mean age of the 234 participants was 20.4 years (SD = 3.4).
Most (81.6%) described themselves as being of White British ethnicity
and female (82.1%). One hundred and ﬁfty-two (65.0%) were studying
psychology, and 82 (35.0%) were studying medicine. One hundred
and eighteen (50.4%) of the participants were randomized to Group 1
(“Person with epilepsy”) and 116 (49.6%) to Group 2 (“Epileptic”).
Table 1 presents a comparison of the participants in the groups. There
were no statistically signiﬁcant differences between the groups on any
measure, including epilepsy knowledge.
3.2. Primary outcome measure
The responses of the two groups to Fernandes et al.'s four questions
were similar, with no statistically signiﬁcant differences being found.
Speciﬁcally, in response to Question 1, 11.9% of those in Group 1
(“Person with epilepsy”) said they would anticipate that those with epi-
lepsy would be rejected by society, while 9.5% fromGroup 2 (“Epileptic”)
said this (proportion difference = 0.02, 95% CI =−0.06 and 0.11). To
Question2, 75.4% fromGroup1 said that they thought thosewith epilepsy
would have more difﬁculties getting employed, compared to 72.4% of
those from Group 2 (difference = 0.03, 95% CI =−0.08 and 0.14). For
Question 3, 76.3% of those from Group 1 said that they thought those
with epilepsy would have more difﬁculties at school, compared to 71.6%
of those from Group 2 (difference= 0.04, 95% CI =−0.06 and 0.15). Fi-
nally, for Question 4, 9.3% of participants fromGroup 1 said that theywere
prejudiced towards those with epilepsy, compared to 5.2% of those from
Group 2 (difference = 0.04, 95% CI =−0.02 and 0.11).
Logistic regression identiﬁed only a small number of statistically sig-
niﬁcant associations between responses to Fernandes et al.s questions
and participant characteristics (Table 2). In unadjusted analyses, being
of non-White British ethnicity was associated with a higher likelihood
of reporting on Question 1 that those with epilepsy are rejected by
society (OR = 2.89, 95% CI = 1.18 and 7.10). For Question 2, studying
medicine rather than psychology was associatedwith beingmore likely
to report that those with epilepsy would experience more difﬁculties
with employment (OR = 1.93, 95% CI = 1.00 and 3.74), as was having
higher preexisting knowledge regarding themedical aspects of epilepsy
(OR = 1.02, 95% CI = 1.01 and 1.05). No other signiﬁcant associations
were found.
3.3. Secondary outcome measure
The responses of the two groups to the ABLE questionnaire were
comparable (Supporting Information Table 1). Therewere no statistical-
ly signiﬁcant differences detected between the groups on any of the
subscales, and mean difference scores ranged from only−0.02 to 0.14.
Linear regression was used to determine if any of the participants'
characteristics were associated with reported attitudes (Table 3). For
the subscale ‘Negative Stereotypes’, social knowledge score was the
only variable that had a signiﬁcant association, with increased knowl-
edge being associated with more positive attitudes (B =−0.004, 95%
CI =−0.008 and−0.001).
For the three other subscales, a number of signiﬁcant associations
were identiﬁed byunivariate screening and entered intomultiple regres-
sion models. In these adjusted analyses, the variable which remained
signiﬁcantly predictive for the subscale ‘Risk and Safety Concerns’ was
Table 1
Participants' characteristics.
Group 1
“Person with epilepsy” (n = 118)
Group 2
“Epileptic” (n = 116)
Difference
(95% CI)
Age
Mean (SD) 20.16 (2.26) 20.69 (3.93) −0.52 (−1.39, 0.34)
Range 18–33 18–42 –
Sex (n/%)
Female 95 (80.5) 97 (83.6) −0.03 (−0.13, 0.06)
Ethnicity (n/%)
White British 94 (79.7) 97 (83.6) −0.03 (−0.14, 0.06)
Degree course (n/%)
Psychology 75 (63.6) 77 (66.4) −0.02 (−0.14, 0.09)
Epilepsy knowledge
Medical knowledge (mean % SD) 80.36 (12.43) 79.36 (12.52) 0.99 (−2.22, 4.21)
Social knowledge (mean % SD) 81.46 (15.65) 80.93 (15.24) 0.54 (−3.45, 4.52)
Known anyone who had epilepsy? (n/%)
No 85 (72.0) 89 (76.7) −0.04 (−0.15, 0.06)
Ever witnessed a seizure? (n/%)
No 68 (57.6) 61 (52.6) 0.05 (−0.07, 0.17)
Do you have epilepsy? (n/%)
No 117 (99.2) 115 (99.1) 0.00 (−0.03, 0.03)
Notes: CI = 95% conﬁdence interval, n = number, SD = standard deviation.
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0.33, 95% CI = 0.05 and 0.62). To have done so was associated with a
more negative attitude. For the subscale ‘Work and Role Expectations’,
higher social knowledge was associated with a more positive attitude
(B =−0.01, 95% CI =−0.02 and−0.01). Having each been found to
hold signiﬁcant unadjusted associations with scores on the ‘Personal
Fear and Avoidance’ subscale, the variables age, medical knowledge,
social knowledge, whether the person knew anyone with epilepsy, and
whether they had seen a seizure were all entered into multiple regres-
sion analyses. None remained signiﬁcant in this adjusted analysis.
4. Discussion
4.1. Main ﬁndings
Fernandes et al. [8] presented evidence from their study with
Portuguese-speaking students in Brazil indicating that the label
“epileptic” provoked more negative attitudes towards those with
epilepsy than “person with epilepsy”. Despite important limitations to
their study, their ﬁnding has had a substantial impact, and their broad
recommendation to stop saying “epileptic” has been widely cited. It has
been assumed that the effect detected by this study is robust and tran-
scends language and culture. The Institute of Medicine has, for example,Table 2
Association between participants' characteristics and responses to Fernandes et al.'s primary o
Characteristic Question 1 Question 2
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Unadjusted O
(95% CI)
Gender (0 = male, 1 = female) 0.51 (0.20, 1.33) – 1.16 (0.55, 2.46
Age (years) 0.96 (0.87, 1.05) – 1.06 (0.97, 1.17
Ethnicity (0 =White British, 1 = other) 2.89 (1.18, 7.10) 2.89 (1.18, 7.10) 2.02 (0.85, 4.84
Degree (0= psychology, 1 =medicine) 1.26 (0.54, 2.97) – 1.93 (1.00, 3.7
Medical knowledge (higher =more
knowledge)
0.98 (0.95, 1.02) – 1.02 (1.01, 1.0
Social knowledge (higher = more
knowledge)
0.99 (0.96, 1.01) – 1.00 (0.98, 1.02
Know anyone with epilepsy
(0 = Yes, 1 = No)
1.14 (0.45, 2.89) – 0.85 (0.44, 1.65
Seen a seizure (0 = Yes, 1 = No) 1.51 (0.64, 3.58) – 0.88 (0.48, 1.59
Model summary Χ2 (1) = 5.39,
P = 0.020
Notes: OR = odds ratio, CI = 95% conﬁdence interval, P b 0.05 shown in bold, Question 1= “Do
“Do you think that people with epilepsy/epileptics have more difﬁculties getting employed?”,
school?”, Question 4 = “Are you prejudiced towards people with epilepsy/epileptics?”. An ansacknowledged the ﬁnding and recommended that “epileptic” should
not be used at all in English [12]. We, for the ﬁrst time, replicated
Fernandes et al.'s study in a different language and culture to explore
how universal the effect of the label is.
Despite using close translations of the questions Fernandes et al.
used and having sufﬁcient statistical power (indeed, we overrecruited),
we did not ﬁnd any effect of using the different terms on our student
participants' views towards thosewith epilepsy.We also foundnoeffect
of the different terms on a secondary outcome measure — namely, the
Attitudes and Beliefs about Living with Epilepsy (ABLE) scale [33]. The
ABLE scale is an established method by which people's attitudes
towards epilepsy can be measured in a standardized way [37,38]. One
advantage is that its construction recognizes that attitudes are multidi-
mensional [33]. It is possible that alternative approaches to capturing
attitudes towards epilepsy, such as detailed interviews, might have re-
vealed more subtle differences in attitudes that were evoked by the dif-
ferent terms and which were not detected by our two measures. This
remains to be determined.
Our ﬁndings do not rule out the possibility that the term “epileptic”
might provoke more negative attitudes than “person with epilepsy” in
parts of the UK population other than students. This is something that
future studies should consider exploring. What our ﬁnding does show,
however, is that the effect of this term is not universal as has beenutcome questions.
Question 3 Question 4
R Adjusted OR
(95% CI)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
) – 0.86 (0.39, 1.89) – 0.49 (0.16, 1.48) –
) – 0.98 (0.90, 1.08) – 0.96 (0.84, 1.09) –
) – 0.89 (0.42, 1.87) – 1.96 (0.65, 5.91) –
4) 1.56 (0.77, 3.16) 1.73 (0.91, 3.32) – 2.21 (0.82, 6.00) –
5) 1.02 (0.99, 1.04) 1.01 (0.98, 1.03) – 1.01 (0.96, 1.04) –
) – 1.01 (−0.99, 1.02) – 0.99 (0.96, 1.03) –
) – 0.77 (0.39, 1.47) – 1.22 (0.41, 3.65) –
) – 0.74 (0.41, 1.34) – 1.53 (0.55, 4.32) –Χ2 (2) = 7.06,
P = 0.029
– –
you think that people with epilepsy/epileptics are rejected by the society?”, Question 2=
Question 3 = “Do you think that people with epilepsy/epileptics have more difﬁculties at
wer of “No” to a question was coded as 0, while an answer of “Yes” was coded as 1.
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serving to illuminate just how limited the body of research is that has
informed the recently made recommendations. Fernandes et al. detect-
ed the effect in a single student sample (within a study with important
methodological limitations), but the recommendations that have since
been made apply to all people in all contexts. Epilepsy-related stigma
deserves more careful and informed consideration than this. To not do
so risks any resulting recommendations being viewed with cynicism
within the parts of the community where they are needed most and
having limited impact. Indeed, it is for this reason that we, despite
personally favoring the use of the term “person with epilepsy” with in
our own research and clinical practice, conducted this study so as to
drawattention to the limited evidence base that has so far been afforded
to this important topic.
4.2. Why might we not have found the same effect in English?
Firstly, the effect might depend on the connotations that the word
“epileptic” has within a culture. While the etymology and direct
meaning of the word “epileptic” in English and Portuguese are similar,
the attitudinal and informational schemata evoked by the term within
student populations in the UK and Brazil may not be. In support of this
possibility, it is known that attitudes and stigma towards epilepsy
do vary between cultures [39]. Indeed, there are epidemiological
differences between the UK and Brazil that could mean some of the
older myths concerning epilepsy remain prevalent in Brazil and
attitudes more negative. Infectious diseases, for instance, have a key
role in causing epilepsy in Brazil [40], and because of a large treatment
gap, uncontrolled epilepsy is common [41]. Our study did not directly
measure or compare the connotations that the two terms held for our
participants. Future studies should consider capturing this information
and comparing what is found in different cultures.
Further support for the explanation that the effectmight be cultural-
ly dependent comes from Friedrich et al.'s [19] recently published study.
They asked Croatian students some locally developed questions about
their attitudes towards those with epilepsy. For half of the students,
those with epilepsy were referred to as “people with epilepsy”, while
for the other half, the terms “epileptics/epileptic children” were used.
The effect of the manipulation was negligible. On only 3 of the 9 ques-
tions they used was a statistically signiﬁcant difference detected, and
these disappeared when a correction for multiple comparisons was ap-
plied. The size of the effect was also small (average difference = 0.16,
possible difference range:−3 to +3).
Greater methodological rigor on the part of our study may also help
explain why we did not replicate Fernandes et al.'s [8] ﬁnding. Firstly,
our participants were randomly allocated, and our two groups were
comparable in their baseline characteristics. Fernandes et al.'s partici-
pants were not randomized, and theremay have been systematic differ-
ences between their two groups, with nomeasure having beenmade of
their participants' preexisting knowledge of epilepsy, familiarity with
the condition, or ethnicity. Unknown differences between their two
groups in these respects could account for why their two groups ap-
peared to respond quite so differently to the attitudinal questions,
while ours did not. Secondly, our study was potentially less susceptible
to “demand characteristics” inﬂuencing how participants responded to
the questions. Participants completed our study online and anonymous-
ly. In contrast, Fernandes et al.'s study was completed in person, with
the questions being read by the experimenter.
One ﬁnal explanation is that the characteristics of our participants
were slightly different to Fernandes et al.'s [8]. Their participants were
high school students identiﬁed for being academically “gifted” ([8],
p. 1281). Ours were university students studying two subjects and
slightly older (by 4 years on average). These differences could have re-
duced the likelihood of us detecting the effect. Age might, for example,
moderate the effect the term “epileptic” has. Even if age or another
characteristic does moderate the effect, this though would not alter
26 A.J. Noble, A.G. Marson / Epilepsy & Behavior 59 (2016) 21–27our conclusion that the effect of the label “epileptic” is not universal as
has been assumed.
4.3. Implications
While our results suggest the term “epileptic” may not have as
negative an effect on attitudes as has been contended, it remains the
case that the term is a divisive one. So how should we proceed, and
what words can one use and not use? At present, more evidence is
needed to permit a truly informed debate. In particular, we have no ev-
idence on the preferences of those actually living with epilepsy and
their reasons. This is something we are currently obtaining for those in
the UK.
Should it be found that there is a preference among those with epi-
lepsy for ‘person-ﬁrst language’, recommendations to move away from
terms such as “epileptic” would become justiﬁed, and this evidence
could help promote adherence to associated recommendations. We
would encourage colleagues from other countries to obtain evidence
on the preferences of those with epilepsy in their communities. It
should not be assumed that the views of health professionals, the volun-
tary sector, or those reﬂected in health policy always align with those of
patients [42]. An example of this comes from the UK where there have
been moves for health professionals, particularly those working within
mental health, to say “service user” or “client”, rather than “patient”
[43,44]. “Patient”, it has been argued, implies passivity, lack of personal
agency, and lack of value. However, like the recommendation regarding
“epileptic”, the call (however well-intentioned) was arguably prema-
ture and not subject to the level of consideration required [45]. Various
surveys have since revealed how, for people using mental health ser-
vices, the term “patient” is actually preferred [46–48]. Reasons proffered
for this include the following: “I believe addiction is an illness. If I was in
with cancer, I would expect to be called a cancer patient, so what is the
difference?” and “I see mental health problems in the same way as
physical problems, and therefore, being called a patient is appropriate
for both” [46].
Another implication of our study is that the consistent use of
‘person-ﬁrst language’ may not be able to promote the positive change
in attitudes towards epilepsy that had been hoped for. Other interven-
tions are likely needed. The results from our examination of what fac-
tors were associated with attitudes towards epilepsy may be helpful
here. Factors we examined included participant age, sex, and ethnicity,
as well as familiarity with epilepsy and knowledge. We found lower
epilepsy knowledge to be the factor most consistently associated with
negative attitudes. This suggests that an educational intervention
targeting knowledgemight improve attitudes. It should be emphasized,
however, that the size of any change in attitudes resulting from such an
interventionmight be small since our ﬁnal predictive models for partic-
ipants' scores on the ABLE scale accounted for between only 3 and 9% of
variance. A similar ﬁnding was reported by Dilorio et al. [33]. That
interventions to increase knowledge about epilepsy among the public
may not always result in improved attitudes or behaviors has been
previously highlighted [49] and is in line with evidence from the more
extensive research literature on mental health stigma [50,51].
4.4. Conclusions
Epilepsy-related stigma deserves careful and informed consider-
ation. We found that, when used in English, the term “epileptic” does
not necessarily provoke more negative attitudes towards those with
epilepsy than “person with epilepsy”. While this ﬁnding does not
argue against the use of the phrase “person with epilepsy”, nor does it
support previous recommendations to stop saying “epileptic”. More ev-
idence, including on the preferences of those living with epilepsy, is re-
quired before any recommendation can be said to be evidence-based.
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